4Front Ventures Corp. (FFNTF)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jun 26, 2025, 9:56 AM EDT
4Front Ventures Revenue
4Front Ventures had revenue of $17.13M in the quarter ending September 30, 2024, a decrease of -25.52%. This brings the company's revenue in the last twelve months to $75.61M, down -27.50% year-over-year. In the year 2023, 4Front Ventures had annual revenue of $97.44M, down -9.50%.
Revenue (ttm)
75.61M
Revenue Growth
-27.50%
P/S Ratio
0.04
Revenue / Employee
195.37K
Employees
399
Market Cap
3.30M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Elite Pharmaceuticals | 70.00M |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
American Oncology Network | 1.76B |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
4Front Ventures News
- 1 day ago - Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 24, 2025 - Benzinga
- 6 days ago - Cannabis Stock Gainers And Losers From June 19, 2025 - Benzinga
- 7 days ago - Cannabis Stock Movers For June 18, 2025 - Benzinga
- 14 days ago - Bullish Sentiment Across The Cannabis Space - Check Full Movers For June 11, 2025 - Benzinga
- 15 days ago - 4Front Initiates Bankruptcy and Insolvency Act Proceedings in Canada - PRNewsWire
- 16 days ago - Cannabis Stock Gainers And Losers From June 9, 2025 - Benzinga
- 4 weeks ago - All 4Front Subsidiaries File for Court-Appointed Receiver - PRNewsWire
- 5 weeks ago - Cannabis Stock Gainers And Losers From May 19, 2025 - Benzinga